Sign in Subscribe
Biotechnology

Efficient CD8+ T Cell Response to HIV-env V3 Loop Epitope with DNA Prime/Vaccinia Virus Boost Immunization

Strategic Insights

— 2 min read

A DNA prime/vaccinia virus boost immunization regime has shown promise in eliciting an efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates. This study, conducted by Spanish researchers, analyzed the antigen-specific immune responses triggered in mice by different combinations of vaccine vehicles expressing the muldepitope polypeptide TAB13. The findings suggest that a protocol incorporating a DNA vector expressing IFN-gamma with DNA-TAB in the priming, followed by a booster with MVA-TAB, triggered the highest values of specific CD8+ T cell response.

Key Takeaways:

  • A DNA prime/vaccinia virus boost immunization regime elicited an efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates.
  • The vaccine candidates against AIDS are designed to enhance the CTL arm of the immune system.
  • The chimeric protein TAB13 contains the V3 region of the gp120 from eight different HIV-1 isolates and was efficiently expressed by a DNA vector (DNA-TAB), and also by vaccinia virus recombinants.
  • The protocol that incorporates a DNA vector expressing IFN-gamma with DNA-TAB in the priming, followed by a booster with MVA-TAB, triggered the highest values of specific CD8+ T cell response.
  • The immune response induced by these vaccination approaches was predominantly of Th-1 type.
  • The findings establish safe strategies for the enhanced generation of T cell mediated immunity to HIV-1 that can benefit in the design of an effective vaccine against AIDS.
  • The study highlights the importance of CD8+ T cell response in the clearance of viral infections.
  • The vaccine vehicles used in this study include DNA-TAB, VV-TAB and MVA-TAB.
  • The researchers found that inoculation of DNA-TAB vector in priming followed by a booster with VV-TAB or MVA-TAB induces a humoral immune response against TAB13 protein.

Statistics:

  • The study found that a protocol incorporating a DNA vector expressing IFN-gamma with DNA-TAB in the priming, followed by a booster with MVA-TAB, triggered the highest values of specific CD8+ T cell response.
  • The immune response induced by this vaccination approach was predominantly of Th-1 type, with a cytokine pattern typical of Th-1 type responses.
  • The vaccine candidates against AIDS are designed to enhance the CTL arm of the immune system.
  • The chimeric protein TAB13 contains the V3 region of the gp120 from eight different HIV-1 isolates.

Sources:

  • Gomez, C. E., et al. "Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (RWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma." Virus Research, vol. 105, no. 1, 2004, pp. 11-22.
  • Consejo Superior de Investigaciones Cientificas (CSIC). Department of Molecular and Cellular Biology. Centro Nacional de Biotecnologia. Campus Universidad Autonoma. 28049 Madrid, Spain.
  • NewsRx.com & NewsRx.net. "Efficient CD8+ T Cell Response to HIV-env V3 Loop Epitope with DNA Prime/Vaccinia Virus Boost Immunization." Health & Medicine Week via NewsRx.net.

Read more